Elf Beauty stock gains on strong sales data from Canaccord tracker

Elf Beauty (ELF) shares rose after Canaccord's sales tracker showed 11.6% year-over-year dollar sales growth, with Naturium brand up 74.3%. Edgewell (EPC) saw 3.0% sales growth, driven by Edge and Cremo shave products. Perrigo (PRGO) reported 9.3% year-over-year growth in private label infant formula sales.

Original reporting
Published Sep 30, 2026, 10:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 10:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$ELF
Bullish
high confidence
Mentioned
$ELF · $EPC · $PRGO
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ELFBullishMed
01

Why it matters

The fresh sales numbers acted as a catalyst for immediate price moves in ELF, EPC, and PRGO.

02

Market read

The article delivers first‑report sales data that moved the stocks of the three companies, offering short‑term trading opportunities.

03

What to watch

Potential supply‑chain constraints or pricing pressure could temper future growth.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Canaccord's two‑week sales tracker provides early‑stage performance data for beauty brands.

Company-level read

Ticker impact

$ELFBullishHigh confidence
Context

Elf Beauty shares rose after Canaccord reported 11.6% YoY sales growth and 17% unit growth in the latest two‑week period.

Expected impact

upward pressure as the market prices in the sales acceleration.

Evidence & confidence

The sales data are fresh, exceed category growth and were the catalyst for the stock's rise.

$EPCBullishMedium confidence
Context

Edgewell Personal Care posted 3% sales growth, with Edge shave up 7.3% YoY, driving a share price increase.

Expected impact

moderate upside as investors view the category rebound favorably.

Evidence & confidence

The sales lift is modest but positive and contributed to the broader beauty rally.

$PRGOBullishMedium confidence
Context

Perrigo saw private‑label infant formula sales rise 9.3% YoY, outpacing the overall category.

Expected impact

potential upward pressure if the trend continues.

Evidence & confidence

The data highlight a niche strength that may attract attention despite the broader market focus on ELF.

Market effects

The beauty and personal‑care sector shows robust short‑term demand, supporting peers.

U.S. consumer discretionary sentiment is reinforced by the sales beat.

Limited to U.S. beauty stocks; no broader macro effect.

Counterpoint

If the sales growth is driven by temporary promotions, the rally may be short‑lived.

Key entities

  • Elf Beauty

    U.S. cosmetics company (ticker ELF).

  • Edgewell Personal Care

    U.S. personal‑care products maker (ticker EPC).

  • Perrigo

    Pharmaceutical and consumer health company (ticker PRGO).

Related articles

$EPCMed

Edgewell Reports 3% Q4 Sales Growth and Adjusted EPS of $0.78

Edgewell reported Q4 2026 net sales of $484.1M, up 3.0%, and adjusted EPS of $0.78. Full-year sales rose 1.8% to $1.997B, with adjusted EPS at $1.93. The company forecasted fiscal 2027 adjusted EPS of $1.85 to $2.15. Growth was driven by North America and International markets, with notable gains in Grooming and Sun and Skin Care segments.

$EPCMed

Edgewell Personal Care beats Q4 estimates on revenue growth

Edgewell Personal Care (EPC) reported Q4 adjusted EPS of $0.78, beating estimates by $0.01, with revenue of $484.1M, up 3.0% YoY. Organic sales grew 3.1%, driven by Wet Shave and Sun & Skin Care segments. Adjusted gross margin expanded 510 bps to 45.7%. For fiscal 2027, EPC guided adjusted EPS to $1.85-$2.15 and organic net sales growth of 1.0%-3.0%.

$EPCMed

Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results Four

$EPCHighAI 8/10

Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

Edgewell Personal Care (EPC) reported Q4 2026 net sales of $484.1M, up 3.0%, and full-year sales of $1.996B, up 1.8%. GAAP EPS was $0.23 for Q4 and $(0.05) for the year, while adjusted EPS was $0.78 and $1.93, respectively. The company expects fiscal 2027 growth in organic sales, adjusted EBITDA, and adjusted EPS. EPC ended Q4 with $375.6M in cash and declared a $0.15 dividend.

$ELFHighAI 8/10

Why is e.l.f. Beauty (ELF) stock soaring today

e.l.f. Beauty (ELF) shares rose 8.5% after Q2 2027 earnings beat estimates, with revenue of $520.8M, up 51.4% YoY. The company raised its full-year outlook, with revenue now expected to reach about $2.02B. ELF has gained 51.6% YTD, reaching a new 52-week high of $118.00 per share.

$PRGOMed

Perrigo Q3 Earnings Call Highlights

Perrigo (PRGO) reported Q3 earnings with net sales declines in self-care and specialty care segments. Adjusted EPS fell to 61 cents, with a lower tax rate providing some benefit. The company expects 2026 sales declines and adjusted EPS of $2.15-$2.35. Perrigo is divesting infant formula and other businesses to simplify operations and reduce debt. Cash and debt at quarter-end were $437M and $3.3B, respectively.